Human clinical trials scheduled
Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ? in the back of the eye ? progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science (IOVS).
The paper, titled Early detection of amyloidopathy in Alzheimer’s mice by hyperspectral endoscopy, builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer’s.
Early detection of Alzheimer’s is critical for two reasons. “First, effective treatments need to be administered well before patients show actual neurological signs,” said author Robert Vince, PhD, of the Center for Drug Design at the University of Minnesota (UMN). “Second, since there are no available early detection techniques, drugs currently cannot be tested to determine if they are effective against early Alzheimer’s disease. An early diagnostic tool like ours could help the development of drugs as well.”
Looking through the eye to see the brain is a key advantage of the new technology. “The retina of the eye is not just ‘connected’ to the brain — it is part of the central nervous system,” said author Swati More, PhD, also of the Center for Drug Design at UMN. While the brain and retina undergo similar changes due to Alzheimer’s disease, “unlike the brain, the retina is easily accessible to us, making changes in the retina easier to observe.”
“We saw changes in the retinas of Alzheimer’s mice before the typical age at which neurological signs are observed,” said More. “The results are close to our best-case scenario for outcomes of this project.”
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- The road to Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatmenton September 26, 2021 at 8:30 pm
Dr. Aaron Kesselheim had been on an advisory committee for the US Food and Drug Administration for a half-dozen years, but he had never been to a meeting like this one.
- Walkers strive to end Alzheimer’s diseaseon September 26, 2021 at 8:00 pm
More than 200 people registered to take part in the Walk to End Alzheimer's, held Saturday at Riverside Park in Beloit.
- Authorities searching for missing Shelby County man with Alzheimer’s diseaseon September 26, 2021 at 5:17 pm
The Shelby County Sheriff’s Office is requesting the public’s help to find an elderly man with a history of Alzheimer’s disease who was last ...
- Walk to End Alzheimer’s returns in-person in Columbuson September 26, 2021 at 3:19 pm
The Columbus Walk to End Alzheimer’s returned in-person Sunday at the Columbus Commons. NBC4’s Colleen Marshall was the emcee for the walk, which raises money for Alzheimer’s ...
- Ticker: Johnny Ramone’s guitar tops $900K at auction; UMass Lowell professor lands $2.7M Alzheimer’s granton September 26, 2021 at 1:55 pm
The primary guitar used by Johnny Ramone, on each of the Ramones records and at nearly 2,000 shows over the band’s career, sold for $937,500 at auction this weekend. The 1965 Mosrite Ventures II ...
- Walk to End Alzheimer's in Kenosha and Racine counties held at UW-Parkside, final tally may exceed $100,000on September 26, 2021 at 12:00 pm
Walkers and teams from across the area participated in this year’s Walk to End Alzheimer’s in Kenosha and Racine counties at the University of Wisconsin-Parkside Student Center on ...
- NEK Walk To End Alzheimer’s Sees Large, Committed Turnouton September 26, 2021 at 10:00 am
Downtown St. Johnsbury was awash on Sunday morning in the color purple and fabric flowers symbolizing the roles of those with Alzheimer’s or dementia, their family and ...
- How Light Therapy Could Help People With Alzheimer's Diseaseon September 26, 2021 at 10:00 am
Light therapy can refer to many things, though it generally describes the use of some kind of light source--whether natural or artificial--to treat certain | Technology ...
- TAU Study Shows Cognitive Boost In Alzheimer’s Patients Using Oxygen Therapyon September 26, 2021 at 3:36 am
An Israeli team remarked that this was the first time that non-drug therapy has been proven effective in Alzheimer's cases.
- ‘Grey’s Anatomy’ Fans Say ‘Absolutely Not’ to Meredith Alzheimer’s Theoryon September 26, 2021 at 2:58 am
Meredith Grey having Alzheimer's disease would be another big hurdle for the 'Grey's Anatomy' character. And fans are saying, 'no.' ...
via Bing News